Catecholamine Release–Inhibitory Peptide Catestatin (Chromogranin A352–372) Naturally Occurring Amino Acid Variant Gly364Ser Causes Profound Changes in …

F Rao, G Wen, JR Gayen, M Das, SM Vaingankar… - Circulation, 2007 - Am Heart Assoc
Background—Chromogranin A, coreleased with catecholamines by exocytosis, is cleaved to
the catecholamine release–inhibitory fragment catestatin. We identified a natural
nonsynonymous variant of catestatin, Gly364Ser, that alters human autonomic function and
blood pressure. Methods and Results—Gly364Ser heterozygotes and controls underwent
physiological and biochemical phenotyping, including catecholamine production,
chromogranin A precursor, and its catestatin product. Case-control studies replicated effects …

[PDF][PDF] Catecholamine Release–Inhibitory Peptide Catestatin (Chromogranin A352–372)

NOAAV Gly364Ser, C Profound - 2007 - Citeseer
Background—Chromogranin A, coreleased with catecholamines by exocytosis, is cleaved to
the catecholamine release–inhibitory fragment catestatin. We identified a natural
nonsynonymous variant of catestatin, Gly364Ser, that alters human autonomic function and
blood pressure. Methods and Results—Gly364Ser heterozygotes and controls underwent
physiological and biochemical phenotyping, including catecholamine production,
chromogranin A precursor, and its catestatin product. Case-control studies replicated effects …
以上显示的是最相近的搜索结果。 查看全部搜索结果